发明名称 AT1-RECEPTOR ANTAGONISTS FOR PREVENTING AND TREATING POSTISCHEMIC RENAL FAILURE AND FOR PROTECTING ISCHEMIC KIDNEYS
摘要 AT1-receptor antagonists and particularly the compound (S)-N-(1-carboxy-2-methylprop-1-yl)-N--pentanoyl-N-[2' (1H-tetrazol-5- yl)biphenyl--4-yl-methyl]amine (valsartan) of formula (I) or a salt thereof, in particular a pharmaceutically acceptable salt thereof, can be used for treating (acute and chronic) postischemic renal failure and for protecting the ischemic kidney.
申请公布号 CA2232663(C) 申请公布日期 2008.04.08
申请号 CA19962232663 申请日期 1996.09.24
申请人 NOVARTIS AG 发明人 HUMKE, ULRICH
分类号 A61K31/41;C07D401/10;A61K31/00;A61K31/415;A61K31/4164;A61K31/4174;A61K31/4178;A61K31/4184;A61K31/4188;A61K31/437;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4439;A61K31/455;A61K31/47;A61K31/4709;A61K31/472;A61K31/4725;A61K45/00;A61P9/10;A61P13/00;A61P13/12;C07D257/04;C07D401/14;C07D403/10;C07D405/06;C07D409/06;C07D471/04 主分类号 A61K31/41
代理机构 代理人
主权项
地址